Altria Group Inc. (MO) exhibits 62.5% gross margins and 48.4% return on invested capital within Health Care (Medicinal Chemicals and Botanical Products), balanced against a 14.7x enterprise multiple and 6.6% implied options volatility.
Sustained 62.5% gross profitability converts into 42.5% operating margin and 48.4% ROIC, outpacing sector cost of capital.
ROIC: 48.4% // GM: 62.5%YoY revenue trajectory of -3.1% paired with 7.08% free cash flow yield supports self-funded R&D and capital return.
REV YOY: -3.1% // FCF YLD: 7.08%Altman Z-Score of 4.90 and Piotroski F-Score of 6/9 indicate low near-term refinancing stress.
ALTMAN Z: 4.90 // F-SCORE: 6/9Trading at 18.4x trailing P/E (17.1x Fwd P/E) leaves valuation vulnerable if real 10Y TIPS yields spike.
P/E: 18.4x // EV/EBITDA: 14.7xOptions market prices a ±6.6% implied move with a 0.54 put/call ratio around $75.00 max pain.
IMPL MOVE: ±6.6% // P/C: 0.54Elevated industry capital intensity and customer concentration in Medicinal Chemicals and Botanical Products require continuous execution to defend 29.8% net margins.
NET MARGIN: 29.8% // D/E: 0.85x| FILER | SIDE | $ VALUE |
|---|---|---|
| INSPECT FULL OWNERSHIP LEDGER IN OWN <GO> | ||
| STRIKE / EXP | TYPE | PREMIUM |
|---|---|---|
| INSPECT GEX & CHAIN IN OPT <GO> | ||
Unblur the exact $50,000 delta-adjusted ETF/options hedge ratio for MO & activate live FRED threshold breach alerts.